started · updated
Géntodos launches genomic medicine laboratory in Mexico
Géntodos, a new Mexican laboratory specializing in genomic medicine, has officially launched operations to expand access to specialized genetic studies within the country. Co-founded by CEO Julián Bravo and supported by a group of investors, the company aims to address existing barriers in Mexico, such as high costs, long turnaround times, and the fragmentation between testing, result interpretation, and clinical application.
The company utilizes an integrated platform that combines high-complexity laboratory infrastructure, automation, sequencing, and bioinformatics. By consolidating these capabilities into a single operation, Géntodos seeks to reduce Mexico's dependence on sending samples abroad and improve the speed of clinical responses. Its portfolio includes studies related to oncology, reproductive health, hereditary genetics, and infectious diseases, with the long-term goal of generating evidence to better understand the genetic diversity of the Mexican population.